{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:44:07Z","timestamp":1789685047567,"version":"4.0.1"},"reference-count":67,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Lagos bat virus (LBV) is a phylogroup II lyssavirus exclusively found in Africa. Previous studies indicated that this virus is lethal to mice after intracranial and intramuscular inoculation. The antigenic composition of LBV differs substantially from that of rabies virus (RABV) and current rabies vaccines do not provide cross protection against phylogroup II lyssaviruses. To investigate the potential role of the LBV matrix protein (M) and glycoprotein (G) in pathogenesis, reverse genetics technology was used to construct recombinant viruses. The genes encoding the glycoprotein, or the matrix and glycoprotein of the attenuated RABV strain SPBN, were replaced with those of LBV resulting in SPBN-LBVG and SPBN-LBVM-LBVG, respectively. To evaluate the immunogenicity of the LBV G, the recombinant RABV SPBNGAS-LBVG-GAS was constructed with the LBV G inserted between two mutated RABV G genes (termed GAS). All the recombinant viruses were lethal to mice after intracranial (i.c.) inoculation although the pathogenicity of SPBNGAS-LBVG-GAS was lower compared to the other recombinant viruses. Following intramuscular (i.m.) inoculation, only SPBN-LBVM-LBVG was lethal to mice, indicating that both the M and G of LBV play a role in the pathogenesis. Most interestingly, serum collected from mice that were inoculated i.m. with SPBNGAS-LBVG-GAS neutralized phylogroup I and II lyssaviruses including RABV, Duvenhage virus (DUVV), LBV, and Mokola virus (MOKV), indicating that this recombinant virus has potential to be developed as a pan-lyssavirus vaccine.<\/jats:p>","DOI":"10.3390\/tropicalmed2030037","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T05:10:01Z","timestamp":1502255401000},"page":"37","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pathogenicity and Immunogenicity of Recombinant Rabies Viruses Expressing the Lagos Bat Virus Matrix and Glycoprotein: Perspectives for a Pan-Lyssavirus Vaccine"],"prefix":"10.3390","volume":"2","author":[{"given":"Joe","family":"Kgaladi","sequence":"first","affiliation":[{"name":"Centre for Emerging and Zoonotic Diseases, National Institute for Communicable Diseases, National Health Laboratory Service, Sandringham 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milosz","family":"Faber","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Dietzschold","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Nel","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Plant Pathology, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7550-0080","authenticated-orcid":false,"given":"Wanda","family":"Markotter","sequence":"additional","affiliation":[{"name":"Centre for Viral Zoonoses, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, Pretoria 0001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"ref_1","unstructured":"King, A.M.Q., Adams, M.J., Carstens, E.B., and Lefkowitz, E.J. (2011). Family Rhabdoviridae. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses, Elsevier."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1071\/MA17006","article-title":"The impact of novel lyssavirus discovery","volume":"38","author":"Banyard","year":"2017","journal-title":"Mcrobiol. Aust."},{"key":"ref_3","unstructured":"(2017, June 15). ICTV. Available online: http:\/\/ictvonline.org\/virusTaxonomy.asp\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virusres.2008.02.001","article-title":"Phylogeny of Lagos bat virus: Challenges for lyssavirus taxonomy","volume":"135","author":"Markotter","year":"2008","journal-title":"Virus Res."},{"key":"ref_5","unstructured":"Coetzer, J.A.W., and Tustin, R.C. (2004). Rabies. Infectious Diseases of Livestock: With Special Reference to Southern Africa, Oxford University Press."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1128\/JCM.00016-08","article-title":"Lagos bat virus in Kenya","volume":"46","author":"Kuzmin","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/infdis\/166.5.972","article-title":"Isolation and characterization of 115 street rabies virus isolates from Ethiopia by using monoclonal antibodies: Identification of 2 isolates as Mokola and Lagos bat viruses","volume":"166","author":"Mebatsion","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_8","first-page":"317","article-title":"Epidemiology and pathogenicity of African bat lyssaviruses","volume":"131","author":"Markotter","year":"2008","journal-title":"Dev. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.3201\/eid1212.060514","article-title":"Isolation of Lagos bat virus from water mongoose","volume":"12","author":"Markotter","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/ojvr.v80i1.511","article-title":"Comparison of pathogenic domains of rabies and African rabies-related lyssaviruses and pathogenicity observed in mice","volume":"80","author":"Kgaladi","year":"2013","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1017\/S0950268808001945","article-title":"Lagos bat virus virulence in mice inoculated by the peripheral route","volume":"137","author":"Markotter","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16328","DOI":"10.1073\/pnas.0407289101","article-title":"Identification of viral genomic elements responsible for rabies virus neuroinvasiveness","volume":"101","author":"Faber","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1128\/JVI.02327-07","article-title":"The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread","volume":"82","author":"Pulmanausahakul","year":"2008","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1128\/JVI.00787-10","article-title":"Molecular basis of neurovirulence of flury rabies virus vaccine strains: Importance of the polymerase and the glycoprotein R333Q mutation","volume":"84","author":"Tao","year":"2010","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.virusres.2006.08.011","article-title":"Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice","volume":"123","author":"Shimizu","year":"2007","journal-title":"Virus Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/153685902317401735","article-title":"New approaches to the development of live attenuated rabies vaccines","volume":"21","author":"Dietzschold","year":"2002","journal-title":"Hybrid. Hybridomics."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/13550280009018301","article-title":"Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach","volume":"6","author":"Morimoto","year":"2000","journal-title":"J. Neurovirol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1099\/vir.0.048827-0","article-title":"Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein","volume":"94","author":"Marston","year":"2013","journal-title":"J. Gen. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/JVI.02220-09","article-title":"Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response","volume":"84","author":"Masatani","year":"2010","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1128\/JVI.75.19.9121-9128.2001","article-title":"Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: Glycoprotein gene is associated with virulence for adult mice","volume":"75","author":"Ito","year":"2001","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"37655","DOI":"10.1074\/jbc.M201374200","article-title":"Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor","volume":"277","author":"Langevin","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1093\/emboj\/17.24.7250","article-title":"Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus","volume":"17","author":"Tuffereau","year":"1998","journal-title":"EMBO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.7053569","article-title":"Is the acetylcholine receptor a rabies virus receptor?","volume":"215","author":"Lentz","year":"1982","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1128\/JVI.72.9.7181-7190.1998","article-title":"The neural cell adhesion molecule is a receptor for rabies virus","volume":"72","author":"Thoulouze","year":"1998","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/JVI.73.1.510-518.1999","article-title":"Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures","volume":"73","author":"Morimoto","year":"1999","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1128\/JVI.78.12.6543-6555.2004","article-title":"Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation","volume":"78","author":"Kassis","year":"2004","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1128\/JVI.77.19.10537-10547.2003","article-title":"Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis","volume":"77","author":"Lay","year":"2003","journal-title":"J. Virol."},{"key":"ref_28","first-page":"219","article-title":"Chimeric rabies viruses for trans-species comparison of lyssavirus glycoprotein ectodomain functions in virus replication and pathogenesis","volume":"9","author":"Genz","year":"2012","journal-title":"Berl. Munch. Tierarztl. Wochenschr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1128\/JVI.01665-09","article-title":"Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation","volume":"84","author":"Finke","year":"2010","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity","volume":"75","author":"Badrane","year":"2001","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0264-410X(88)90184-3","article-title":"Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: An experimental study in mice","volume":"6","author":"Lafon","year":"1988","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1016\/j.vaccine.2009.06.095","article-title":"Antibodies induced by vaccination with purified chick embryo cell culture vaccine (PCECV) cross-neutralize non-classical bat lyssavirus strains","volume":"27","author":"Malerczyk","year":"2009","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of rabies biologics against new lyssaviruses from Eurasia","volume":"111","author":"Hanlon","year":"2005","journal-title":"Virus Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","author":"Brookes","year":"2005","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14760584.4.4.533","article-title":"Vaccines for lyssaviruses other than rabies","volume":"4","author":"Nel","year":"2005","journal-title":"Expert Rev. Vaccines"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1099\/vir.0.061952-0","article-title":"Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus","volume":"95","author":"Horton","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virusres.2010.01.018","article-title":"Shimoni bat virus, a new representative of the Lyssavirus genus","volume":"149","author":"Kuzmin","year":"2010","journal-title":"Virus Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1073\/pnas.0905640106","article-title":"Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus","volume":"106","author":"Faber","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.2006.tb03785.x","article-title":"Characterization of recombinant rabies virus carrying double glycoprotein genes","volume":"50","author":"Ito","year":"2006","journal-title":"Microbiol. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-8-454","article-title":"Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production","volume":"8","author":"Tao","year":"2011","journal-title":"Virol. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/605949","article-title":"Replication-deficient rabies virus\u2013based vaccines are safe and immunogenic in mice and monhuman primates","volume":"200","author":"Cenna","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-\u03b2 expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"Faul","year":"2008","journal-title":"Virology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.01552-10","article-title":"Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination","volume":"85","author":"Wen","year":"2011","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1128\/JVI.00326-10","article-title":"Expression of MIP-1\u03b1 (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells","volume":"84","author":"Zhao","year":"2010","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1128\/JVI.75.22.10800-10807.2001","article-title":"Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity","volume":"75","author":"Pulmanausahakul","year":"2001","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1128\/JVI.00357-07","article-title":"Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus","volume":"81","author":"Faber","year":"2007","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14141","DOI":"10.1128\/JVI.79.22.14141-14148.2005","article-title":"A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity","volume":"79","author":"Faber","year":"2005","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J."},{"key":"ref_51","unstructured":"(2017, June 15). ProMED-mail. Rabies, bat-France. Available online: http:\/\/www.promedmail.org."},{"key":"ref_52","unstructured":"Aubert, F.A. (2017, June 15). Rabies in individual countries: France. Available online: http:\/\/www.who-rabiesbulletin.org\/."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01314672","article-title":"Plaque formation of herpes virus hominis type 2 and rubella virus in variants isolated from the colonies of BHK21\/WI-2 cells formed in soft agar","volume":"53","author":"Sato","year":"1977","journal-title":"Arch. Virol."},{"key":"ref_54","unstructured":"Meslin, F.-X., Kaplan, M.M., and Koprowski, H. (1996). The fluorescent antibody test: p 89\u201385. Laboratory Techniques in Rabies, World Health Organization. [4th ed.]."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_56","unstructured":"Meslin, F.-X., Kaplan, M.M., and Koprowski, H. (1996). A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody. Laboratory Techniques in Rabies, World Health Organization."},{"key":"ref_57","unstructured":"McCulloch, S.D. (2013). Barcoding of South African bat species and evaluation of their natural exposure to lyssaviruses. [Master\u2019s Thesis, University of Pretoria]."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1128\/jvi.69.3.1444-1451.1995","article-title":"Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles","volume":"69","author":"Mebatsion","year":"1995","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/iai.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect. Immun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"9165","DOI":"10.1073\/pnas.84.24.9165","article-title":"Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein","volume":"84","author":"Dietzschold","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0092-8674(00)81072-7","article-title":"Budding of rabies virus particles in the absence of the spike glycoprotein","volume":"84","author":"Mebatsion","year":"1996","journal-title":"Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1099\/0022-1317-81-9-2147","article-title":"Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: An in vitro and in vivo study","volume":"81","author":"Etessami","year":"2000","journal-title":"J. Gen. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/JVI.73.1.242-250.1999","article-title":"Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G","volume":"73","author":"Mebatsion","year":"1999","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/S0264-410X(01)00064-0","article-title":"Genetic engineering of live rabies vaccines","volume":"19","author":"Morimoto","year":"2001","journal-title":"Vaccine"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1017\/S0950268807008965","article-title":"Cross-protective and cross-reactive immune responses to recombinant vaccinia viruses expressing full-length lyssavirus glycoprotein genes","volume":"136","author":"Weyer","year":"2008","journal-title":"Epidemiol. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","article-title":"DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses","volume":"16","author":"Bahloul","year":"1998","journal-title":"Vaccine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1073\/pnas.89.15.7252","article-title":"Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system","volume":"89","author":"Dietzschold","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/2\/3\/37\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:41:53Z","timestamp":1760208113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/2\/3\/37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9]]}},"alternative-id":["tropicalmed2030037"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed2030037","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]}}}